Diagnosis of recurrent XXXX with fine-needle aspiration cytology.

@entity1 @entity66 @entity5 @entity1173
Between 1980-1985, 177 fine-needle @entity1173 were performed on 139 @entity1 suspected of having recurrent @entity5 . Suspected sites of recurrence included a pelvic mass (122), peripheral lymph node (39), and a variety of other locations (16). There were 69 positives, 79 negatives, eight suspicious specimens, and 21 specimens inadequate for interpretation. Excluding suspicious or inadequate specimens, the results of the remaining 148 evaluable @entity1173 were confirmed by histopathologic correlation (35) or subsequent clinical course (113). Because there were no false positives, the specificity of the technique was 100%. The sensitivity was 68%, with an associated false-negative rate of 32%. The predictive value of a positive was 100%; that of a negative was 57%. An analysis of the false-negative results failed to show a correlation with cell type, lesion location, previous radiotherapy, or previous chemotherapy. The complication rate was less than 1%. These data support the conclusion that fine-needle aspiration cytology is a safe, highly specific method for diagnosing recurrent @entity5 . However, in @entity1 with negative fine-needle aspiration cytology and suspected @entity66 , it would appear that further evaluation is indicated.
